Low-Dose Interleukin-2 Therapy: Effects in Chronic Renal Allograft Dysfunction.

被引：0
|
作者：
Schachtner, T. [1 ,2 ]
Stein, M. [2 ]
Sattler, A. [2 ]
Landwehr-Kenzel, S. [2 ]
Sawitzki, B. [2 ]
Reinke, P. [1 ,2 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Charite, Berlin Brandenburg Ctr Regenerat Med, D-13353 Berlin, Germany
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01585
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A268
引用
收藏
页码：475 / 476
页数：2
相关论文
共 50 条
  • [31] Low-dose interleukin-2 therapy is not associated with cutaneous toxicity after autologous transplantation
    LopezJimenez, J
    DelasHeras, E
    Hilara, Y
    GarciaLarana, J
    PerezOteyza, J
    Bellas, C
    Munoz, A
    Rocamora, A
    Nunez, M
    Odriozola, J
    BONE MARROW TRANSPLANTATION, 1996, 18 (02) : 481 - 482
  • [32] Low-Dose Interleukin-2 Therapy: A Driver of an Imbalance between Immune Tolerance and Autoimmunity
    Kosmaczewska, Agata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (10) : 18574 - 18592
  • [33] Efficacy and safety of low-dose interleukin-2 therapy in active Sjogren's syndrome
    He, Jing
    Jin, Yuebo
    Zhang, Ruijun
    Chen, Jiali
    Wang, Han
    Ambrus, Julian L., Jr.
    Jacoub, Alexander
    Sun, Xiaolin
    Li, Zhanguo
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S252 - S252
  • [34] LOW-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY - RATIONALE AND POTENTIAL CLINICAL-APPLICATIONS
    CALIGIURI, MA
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 3 - 10
  • [35] Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma
    Karp, SE
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (01): : 56 - 61
  • [36] Low-Dose Interleukin-2 and HCV-Induced Vasculitis
    Oo, Ye Htun
    Mutimer, David
    Adams, David H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14): : 1353 - 1354
  • [37] Low-Dose Interleukin-2 Treatment of Refractory Lupus Nephritis
    Zhang, Xia
    He, Jing
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [38] Low-dose interleukin-2: A potential treatment for pemphigus vulgaris
    Long, Hai
    Liao, Jieyue
    Yang, Miao
    Wang, Xin
    Zhang, Guiying
    Lu, Qianjin
    AUTOIMMUNITY REVIEWS, 2021, 20 (10)
  • [39] Phase II clinical trial of low-dose interleukin-2, interferon-alpha, and low-dose tegafur uracil therapy for advanced renal cell cancer.
    Kato, Tomoyuki
    Iwamura, Masatsugu
    Fujita, Tetsuo
    Saito, Seiichi
    Ohshiro, Yoshinori
    Imai, Tomoyuki
    Kawata, Nozomu
    Tomita, Yoshihiko
    Sejima, Takehiro
    Kishida, Takeshi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [40] Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus
    Wang, Naidi
    Jin, Yuebo
    Cheng, Gong
    Zhang, Kai
    Huang, Bo
    Li, Yuhui
    He, Jing
    ANNALS OF MEDICINE, 2023, 55 (02)
12345